SCHEMBL7189288

SCHEMBL7189288

CCOc1c(C(C)C)cc(C(C)C)c(O)c1C=CC(=O)c1ccc(O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.52
MAOB P27338 4/20 0.52
LMNA P02545 2/20 0.45
POLB P06746 1/20 0.45
CYP1A1 P04798 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP1B1 Q16678 2/20 0.43
MAPT P10636 3/20 0.42
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAOA P21397 1/20 0.41
CAPN1 P07384 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
F3 P13726 2/20 0.41
P4HB P07237 1/20 0.40
CALM1 P0DP23 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7189283 1.00 ABCG2 (0.52) ABCG2MAOBLMNAPOLBCYP1A1
SCHEMBL7185637 0.92 ABCG2 (0.53) ABCG2MAOBLMNAPOLBCYP1A1
SCHEMBL7185636 0.92 ABCG2 (0.53) ABCG2MAOBLMNAPOLBCYP1A1
SCHEMBL7181129 0.91 CA1 (0.44) ABCG2MAOBLMNACYP1A1CYP1A2
SCHEMBL7181138 0.91 CA1 (0.44) ABCG2MAOBLMNACYP1A1CYP1A2
SCHEMBL7178684 0.89 MAOB (0.40) ABCG2MAOBLMNACYP1A1CYP1A2
SCHEMBL7178680 0.89 MAOB (0.40) ABCG2MAOBLMNACYP1A1CYP1A2
SCHEMBL7186236 0.88 CTSL (0.49) ABCG2MAOBMAPTALDH1A1CAPN1
SCHEMBL7186231 0.88 CTSL (0.49) ABCG2MAOBMAPTALDH1A1CAPN1
SCHEMBL7177335 0.87 ABCG2 (0.43) ABCG2MAOBPOLBMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed